SynthesisFrontiers in medicine2025
Trends and collaborations in discoid lupus erythematosus research: a bibliometric analysis from 2010 to 2024.
Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- From empirical treatment to precision intervention: a multi-database bibliometric analysis of neuropsychiatric systemic lupus erythematosus (2006-2025).Frontiers in immunology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Discoid lupus erythematosus (DLE) is a chronic autoimmune skin disorder. Research fragmentation in DLE limits cohesive clinical and scientific progress. This bibliometric analysis aimed to clarify publication trends, collaboration networks, and emergent research themes in DLE from 2010 to 2024. Methods: A comprehensive search of the Web of Science Core Collection (WoSCC) used the terms "discoid lupus erythematosus" OR "lupus erythematosus discoid." English-language articles and reviews ( Results: Annual publications increased notably after 2018, although average citation rates declined. A small group of prolific authors, led by WERTH VP, contributed disproportionately. The United States dominated publication volume and international collaboration, followed by Italy, the United Kingdom, Germany, and China. Keywords analysis showed a shift from initial emphasis on disease classification and diagnosis toward advanced therapies, immunological mechanisms. Conclusion: Despite growing interest in DLE, it remains underrepresented compared with systemic lupus erythematosus. Broader collaborations, refined diagnostic criteria, and robust clinical trials are essential to enhance therapeutic strategies and patient outcomes in DLE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.